Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bloomsbury Bioseed Fund (BBF) is a London-based seed-stage venture capital fund that specializes in financing early-stage life science spin-out companies. Formed as a collaborative effort between University College London, the London School of Hygiene & Tropical Medicine, the Royal Veterinary College, and Birkbeck, University of London, the fund bridges the gap between academic research and commercialization. BBF provides initial capital and strategic guidance to startups emerging from these world-class research institutions, focusing on sectors such as biotechnology, medical devices, and veterinary science. By leveraging the expertise of its partner institutions, the fund aims to accelerate the development of innovative healthcare solutions and therapeutic technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bloomsbury Bioseed Fund.